Cytogenetics Market by Product, Technique, Application, and End-User - Global Opportunity Analysis and Industry Forecast, 2018-2025

Description Table of
Contents Summary Companies Mentioned Methodology

FEATURED COMPANIES

Empire Genomics, LLC
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Irvine Scientific.
MetaSystems
PerkinElmer Inc.
MORE

Cytogenetics is a branch of science, which deals with the study of cytology and genetics in coordination. Cytology includes the study of components of cells such as chromosomes, whereas genetics is the study of arrangement of genes of an individual. Thus, cytogenetics is applied in the detection and treatment of genetic disorders. The detection is based anomalies in the chromosomal patterns such as missing chromosomes, extra chromosomes, and others. These genetic disorders include cancer, cystic fibrosis, sickle cell anemia, Huntington’s disease, and others. Moreover, cytogenetics is an approach used to formulate targeted cancer therapies and personal medicines.

The global cytogenetics market was valued at $1,121 million in 2017, and is projected to reach $3,097 million by 2025 at a CAGR of 13.5% from 2018 to 2025. The growth of this market is majorly driven by increase in incidence of genetic disorders and cancer. In addition, rise in focus on targeted cancer treatment, surge in geriatric population, and rise in prevalence of chronic diseases significantly contribute the growth of the market. However, lack of awareness about cytogenetics hinders the growth of the global market. Conversely, high market potential in the untapped emerging economies is anticipated to serve as an attractive opportunity during the forecast period.

The global cytogenetics market is segmented into product, technique, application, end user, and region. On the basis of product, the market is categorized into consumables, instruments, and software & services. By technique, it is divided into comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others. The applications covered in this study include genetic disorders, cancer, personalized medicine, and others. Depending on end user, the market is fragmented into clinical & research laboratories, pharmaceutical and biotechnology companies, academic research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global cytogenetics market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
A comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on global and regional scales are provided.
The profiles of key players and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key market segments

By Product

Consumables
Testing Kits, Media, and Reagents
Probes
Others(Affinity Reagents and Stains)
Instruments
Software & Services

By Techniques

Comparative Genomic Hybridization
Fluorescence in Situ Hybridization
Karyotyping
Immunohistochemistry
Others

By Application

Genetic Disorders
Cancer
Personalized Medicine
Others

By End User

Clinical & Research Laboratories
Pharmaceutical & Biotechnology Companies
Academic Research Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories Abbott Laboratories
Agilent Technologies, Inc.
Applied Spectral Imaging, Inc.
Empire Genomics, LLC
Illumina, Inc.
Irvine Scientific.
OPKO Health, Inc. (GeneDx.)
PerkinElmer Inc.
Sysmex Corporation (Oxford Gene Technology)
Thermo Fisher Scientific, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
MetaSystems

Frequently Asked Questions about the Global Cytogenetics Market

What is the estimated value of the Global Cytogenetics Market?

The Global Cytogenetics Market was estimated to be valued at $1121.0 million in 2017.

What is the growth rate of the Global Cytogenetics Market?

The growth rate of the Global Cytogenetics Market is 13.5%, with an estimated value of $3097.0 million by 2025.

What is the forecasted size of the Global Cytogenetics Market?

The Global Cytogenetics Market is estimated to be worth $3097.0 million by 2025.

Who are the key companies in the Global Cytogenetics Market?

Key companies in the Global Cytogenetics Market include Abbott Laboratories Abbott Laboratories, Agilent Technologies, Inc., Applied Spectral Imaging, Inc., Empire Genomics, LLC, Illumina, Inc., Irvine Scientific., OPKO Health, Inc. (GeneDx.), PerkinElmer Inc. and Thermo Fisher Scientific, Inc..

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Empire Genomics, LLC
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Irvine Scientific.
MetaSystems
PerkinElmer Inc.
MORE

Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 CYTOGENETICS MARKET, BY PRODUCT

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. Consumable
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type
4.2.2.1. Testing kits, media, and reagents
4.2.2.1.1. Market size and forecast
4.2.2.2. Probes
4.2.2.2.1. Market size and forecast
4.2.2.3. Others(affinity reagents and stains)
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Instrument
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & service
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE

5.1. Overview
5.1.1. Market size and forecast
5.2. Comparitive genome hybridization
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Fluorescence in situ hybridization
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Karyotyping
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Immunohistochemistry
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

Chapter 6 CYTOGENETICS MARKET, BY APPLICATION

6.1. Overview
6.1.1. Market size and forecast
6.2. Genetic disorder
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Personalized medicine
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Other
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter 7 CYTOGENETICS MARKET, BY END USER

7.1. Overview
7.1.1. Market size and forecast
7.2. Clinical and research laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Pharmaceutical and biotechnology company
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Academic Research Institute
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
7.5. Other
7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country

Chapter 8 CYTOGENETICS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast
8.2.2.1. U.S. market size and forecast
8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user
8.2.2.2. Canada market size and forecast
8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user
8.2.2.3. Mexico market size and forecast
8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user
8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user
8.3. EUROPE
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast
8.3.2.1. Germany market size and forecast
8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user
8.3.2.2. France market size and forecast
8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user
8.3.2.3. UK market size and forecast
8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user
8.3.2.4. Italy market size and forecast
8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user
8.3.2.5. Spain market size and forecast
8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user
8.3.2.6. Rest of Europe market size and forecast
8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user
8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user
8.4. ASIA-PACIFIC
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast
8.4.2.1. Japan market size and forecast
8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user
8.4.2.2. China market size and forecast
8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user
8.4.2.3. India market size and forecast
8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user
8.4.2.4. Australia market size and forecast
8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user
8.4.2.5. South Korea market size and forecast
8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user
8.4.2.6. Rest of Asia-Pacific market size and forecast
8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast
8.5.2.1. Brazil market size and forecast
8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user
8.5.2.2. Saudi Arabia market size and forecast
8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user
8.5.2.3. South Africa market size and forecast
8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user
8.5.2.4. Rest of LAMEA market size and forecast
8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user

Chapter 9 COMPANY PROFILES

9.1. Abbott Laboratories
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. Agilent Technologies, Inc.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. Applied Spectrial Imaging, Inc.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. Empire Genomics, LLC
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. Illumina, Inc.
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. Irvine Scientific
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. OPKO Health, Inc.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. PerkinElmer, Inc.
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. Sysmex Corporation
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Empire Genomics, LLC
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Irvine Scientific.
MetaSystems
PerkinElmer Inc.
MORE

According to a new report, titled, "Cytogenetics Market, By Product, Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $1,121 million in 2017, and is projected to reach $3,097 million in 2025, registering a CAGR of 13.5% from 2018 to 2025.

Cytogenetics is a branch of biology, which correlates cytology and genetics. The correlation is used to study chromosomes and genes in cells and tissues. The study is conducted in relation to hereditary and variations in genes and number of chromosomes, which are used for the detection of genetic disorders as well as selection of precise therapies for treatment of these genetic disorders. Cytogenetics includes various techniques such as comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others. These techniques require the use of cytogenetic products such as testing kits, media, and reagents; probes; consumables; instruments; and software & services. These product and techniques are used for the screening of genetic disorders and designing personal medicine.

Increase in prevalence of cancer & genetic disorders, rise in global geriatric population along with surge in prevalence of chronic diseases, and surge in awareness related to acceptance of personalized medicines across the world are the factors that drive the global cytogenetics market growth. However, higher cost of advanced cytogenetic instruments is expected to impede the market growth. Conversely, shift from fish to array-based techniques is expected to provide many opportunities during the forecast period.

The utilization rate of testing kits, media, and reagents is high, as they are the essential elements of every cytogenetic technique performed. However, the software & services segment is expected to grow at a high CAGR during the forecast period.

The comparative genomic hybridization segment is the largest segment in the global cytogenetics market, and is anticipated to grow at a high CAGR during the forecast period. The clinical & research laboratories segment is expected to grow at a moderate CAGR in the near future. On the other hand, the pharmaceutical & biotechnology companies segment is anticipated to record a high CAGR during the forecast period.

Key findings of the Cytogenetics Market:

The testing kits, media, and reagents segment accounted for approximately three-fourths share of the global cytogenetics consumables market in 2017.
The comparative genomic hybridization segment is expected to grow at a CAGR of 10.5% from 2018 to 2025.
North America accounted for the majority of the share of the global market revenue in 2017.
Asia-Pacific is expected to provide lucrative market growth opportunities, registering a CAGR of 12.1% from 2018 to 2025.

North America was the leading revenue contributor to the global cytogenetics market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the presence of majority of major key players in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness towards early screening of genetic disorders.

The key players of this market include Abbott Laboratories, Agilent Technologies, Inc., Applied Spectral Imaging, Inc., Empire Genomics, LLC., Illumina, Inc., Irvine Scientific., OPKO Health, Inc. (GeneDx.), PerkinElmer Inc., Sysmex Corporation (Oxford Gene Technology), and Thermo Fisher Scientific, Inc. Other players (these players are not profiled in the report and the same can be included on request) in the value chain include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and MetaSystems.

Note: Product cover images may vary from those shown

Abbott Laboratories Abbott Laboratories
Agilent Technologies, Inc.
Applied Spectral Imaging, Inc.
Empire Genomics, LLC
Illumina, Inc.
Irvine Scientific.
OPKO Health, Inc. (GeneDx.)
PerkinElmer Inc.
Sysmex Corporation (Oxford Gene Technology)
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
MetaSystems

Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...

FEATURED COMPANIES

What is the estimated value of the Global Cytogenetics Market?

What is the growth rate of the Global Cytogenetics Market?

What is the forecasted size of the Global Cytogenetics Market?

Who are the key companies in the Global Cytogenetics Market?

FEATURED COMPANIES

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

Molecular Cytogenetics - Global Market Trajectory & Analytics

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Cytogenetics - Technologies, Markets & Companies

Molecular Cytogenetics Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application, Product Type

Molecular Cytogenetics Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028